CHALFONT ST. GILES, UK and CHARLOTTE, NC – 17 August 2016 – GE Healthcare’s Life Sciences business, a global provider of technologies and expertise to the biopharmaceutical and life sciences industries and Sealed Air Corporation, a global manufacturer of primary films for pharmaceutical solutions, today announced the expansion of a strategic alliance designed to further... Read more
Chalfont St Giles, UK – 13 July 2016 – GE Healthcare has acquired Biosafe Group SA, a supplier of integrated cell bioprocessing systems for the rapidly growing cell therapy and regenerative medicine industry for an undisclosed sum. The acquisition of Biosafe expands GE Healthcare’s end-to-end ecosystem of products, solutions and services for our cell therapy... Read more
It’s Time For Polish Engineers to Shine Immelt: We will design and manufacture aircraft engines in Italy, Poland, and the Czech Republic Warsaw, 20 June 2016 Q: You’re on your journey across Europe as it’s going through one crisis after another. We’re now in the midst of the migrant crisis, and Great Britain may soon... Read more
CHALFONT ST. GILES, UK – 13 June 2016 – GE Healthcare’s Life Sciences business today launched the first of a next generation of BiacoreTM systems harnessing Surface Plasmon Resonance (SPR) technology. Biacore 8K marks the start of a new generation of Biacore systems maintaining the high data quality expected from Biacore at high throughput. New... Read more
San Diego, CA – June 12, 2016 – GE Healthcare (NYSE:GE) showcased new molecular imaging technologies at the Society of Nuclear Medicine and Molecular Imaging (SNMMI) 2016 that will enable clinicians to deliver personalized, quantitative results to patients. The Discovery MI system and Discovery NM/CT 670 CZT will help clinicians guide treatment, support patients with... Read more
CHALFONT ST. GILES, UK and KINGSTON, ONTARIO, CANADA – 8 June 2016 – PnuVax Incorporated (PnuVax), a vaccine and biopharmaceutical company, and GE Healthcare’s Life Sciences business (NYSE: GE) announced today that they have entered an agreement under which PnuVax can acquire GE Healthcare’s intellectual property (IP) relating to an inactivated yellow fever vaccine. Under... Read more
CHALFONT ST. GILES, UK AND RIYADH, SAUDI ARABIA – 31 May 2016 – GE Healthcare is entering into a vaccine collaboration with the National Industrial Clusters Development Program (NICDP) under the Ministry of Energy, Industry and Mineral Resources, SaudiVax and King Saud University, to enable vaccine self-sufficiency and pandemic preparedness in the Kingdom of Saudi... Read more
PHOENIX, Ariz.—May 19, 2016 – GE Healthcare (NYSE: GE) and Accenture (NYSE: ACN) today introduced a new offering to help improve medical claims processing and related cash flow for healthcare providers. The alliance, targeting medical claims management, one of the largest areas of lost revenue in the U.S. healthcare system, was announced at GE Healthcare’s... Read more
WAUWATOSA, WI – May 18, 2016 – GE Healthcare and The Health Management Academy (The Academy) today announced a renewed collaboration and will continue advancing healthcare by training healthcare leaders through The Academy GE Fellows Program. Each year, 35 healthcare leaders graduate from The Academy GE Fellows Program. This two-year comprehensive leadership development program targets high... Read more
CHALFONT ST. GILES, UK and UPPSALA, SWEDEN – 13 May 2016 – GE Healthcare Life Sciences continues to invest in Uppsala. The company signs a two-year collaboration agreement with Uppsala BIO. The goal is to find technologies and equipment that support the production and processing of biopharmaceuticals in the future. “Although we are a large,... Read more